Amryt to report q1 2021 results and host conference call & webcast on may 5

Dublin, ireland, and boston ma, april 15, 2021, amryt (nasdaq: amyt, aim: amyt), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that its unaudited financial results for the first quarter 2021 will be released on wednesday, may  5, 2021 at 0700 edt/1200 bst.
AMYT Ratings Summary
AMYT Quant Ranking